PH
Publicaties op Oncologisch.com
Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olapari...
Predictive value of BRCA1/RAD51C methylation in HGSOC - An ancillary study of the PAOLA-1/ENGOT-ov25 phase 3 trial.
Efficacy of subsequent therapies in patiënten met gevorderd ovarian cancer who relapse after eerstelijns olaparib mai...
Olaparib plus bevacizumab onderhoud bij ovariumcarcinoom: PAOLA-1 definitieve OS
Endometriumcarcinoom: ESMO 2022 richtlijn
Topotecan-carboplatine versus paclitaxel-carboplatine of gemcitabine-carboplatine bij platinagevoelig recidief ovariumcarcinoom
Management van borderline ovariumtumoren: overzicht